Outcomes in Lung Cancer Patients Treated with Denosumab

AI Tools May Enhance Lung Cancer Screening and Risk Prediction

AI-powered imaging tools are enhancing lung cancer risk assessment by identifying high-risk patients earlier, expanding screening opportunities, and supporting more equitable, personalized detection strategies.

Glucocorticoids May Reduce Mortality in Community-Acquired Pneumonia

Adjunctive glucocorticoids may improve outcomes in hospitalized community-acquired pneumonia, offering a low-cost, scalable strategy to reduce mortality and strengthen care in resource-limited settings.

Bariatric Surgery: Understanding Risks, Weight Regain, and Medications

Bariatric surgery is evolving into a long-term obesity management strategy, emphasizing continuous medical, nutritional, and behavioral support to improve outcomes and reduce weight regain.

FDA Approves IND for Phase 3 Trial of iSCIB1+ in Melanoma

FDA approval of a phase 3 trial for the iSCIB1+ melanoma vaccine advances personalized cancer treatment, offering potential survival benefits for patients with advanced disease.

Outcomes in Lung Cancer Patients Treated with Denosumab

Denosumab may improve survival and reduce skeletal complications in lung cancer patients with bone metastases, supporting more comprehensive and effective oncology care.